ランダム化,ダブルブラインド,プラセボ対照試験の健康な参加者におけるベキサセリンの複数の上昇用量の安全性,耐受性,薬理動力学および薬理動力学
Jonathan Williams1, Rosa Chan1, Chad Orevillo2
1Lundbeck LLC, Deerfield, IL, USA.
Clinical pharmacology in drug development
|August 30, 2025
まとめ
新型5-HT2C受容体アゴニストであるベキシカセリンは,発育性性脳症における第1相試験において安全で良好な耐容性を示した. 薬剤は迅速に吸収され,投与量に比例して増加し,さらなる臨床開発を支援しました.
科学分野:
- 薬理学について
- 神経科学
- 臨床試験
背景:
- ベキシカセリン (LP352) は選択的5 - ヒドロキシトリプタミン2C (5- HT2C) 受容体のスーパーアゴニストです.
- 発育性および性脳症に関連する発作の治療のために開発中です.
研究 の 目的:
- ベキサセリンの安全性,耐受性,および薬動性を評価する.
- 健康な被験者におけるベキサセリンの効果を,複数の上昇用量試験で評価する.
主な方法:
- 1期,ダブルブラインド,プラセボ対照多重上昇用量 (MAD) 試験
- ベキサセリンの投与量 (3~24 mg TID) を最大14日間投与する.
- バイオマーカーとして血/尿の連続サンプルとプロラクチンの評価
主要な成果:
- ベキシカセリンは安全で,吸収が迅速 (Tmax ~ 1~ 2時間) であった.
- 多重投与後に観察されたベキサセリンとその主要代謝産物 (M20) の蓄積.
- プロラクチン濃度との相関は弱かった.
結論:
- ベキシカセリンは,健康な被験者に好ましい安全性および薬動性プロファイルを示した.
- 発見は,性脳症に対するベキサセリンの継続的な開発を支持する.
- 薬剤は,プロラクチン変化によって示されるように,中央の5-HT2C受容体を活性化します.
関連する概念動画
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Blinding
2.6K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.6K
Blind Procedures
12.1K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.1K
Clinical Trials
7.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.8K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Anxiolytic Drugs: Benzodiazepines and Buspirone
1.2K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
1.2K


